AMED vs USPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Buy and USPH is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileUSPH’s FA Score has 1 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- USPH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 6 TA indicator(s) are bullish while USPH’s TA Score has 5 bullish TA indicator(s).
- AMED’s TA Score: 6 bullish, 3 bearish.
- USPH’s TA Score: 5 bullish, 4 bearish.
Price Growth
AMED (@Medical/Nursing Services) experienced а -0.86% price change this week, while USPH (@Medical/Nursing Services) price change was +7.09% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.89%. For the same industry, the average monthly price growth was +9.27%, and the average quarterly price growth was +10.91%.
Reported Earning Dates
AMED is expected to report earnings on Jul 23, 2025.
USPH is expected to report earnings on Aug 06, 2025.
Industries' Descriptions
@Medical/Nursing Services (+3.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| AMED | USPH | AMED / USPH | |
| Capitalization | 3.02B | 1.69B | 179% |
| EBITDA | 129M | 74.4M | 173% |
| Gain YTD | 5.100 | -12.293 | -41% |
| P/E Ratio | 1170.50 | 87.62 | 1,336% |
| Revenue | 2.24B | 605M | 370% |
| Total Cash | 126M | 153M | 82% |
| Total Debt | 487M | 259M | 188% |
AMED | USPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 80 | |
SMR RATING 1..100 | 77 | 82 | |
PRICE GROWTH RATING 1..100 | 51 | 61 | |
P/E GROWTH RATING 1..100 | 48 | 97 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
USPH's Valuation (32) in the Medical Or Nursing Services industry is somewhat better than the same rating for AMED (76). This means that USPH’s stock grew somewhat faster than AMED’s over the last 12 months.
USPH's Profit vs Risk Rating (80) in the Medical Or Nursing Services industry is in the same range as AMED (100). This means that USPH’s stock grew similarly to AMED’s over the last 12 months.
AMED's SMR Rating (77) in the Medical Or Nursing Services industry is in the same range as USPH (82). This means that AMED’s stock grew similarly to USPH’s over the last 12 months.
AMED's Price Growth Rating (51) in the Medical Or Nursing Services industry is in the same range as USPH (61). This means that AMED’s stock grew similarly to USPH’s over the last 12 months.
AMED's P/E Growth Rating (48) in the Medical Or Nursing Services industry is somewhat better than the same rating for USPH (97). This means that AMED’s stock grew somewhat faster than USPH’s over the last 12 months.
| AMED | USPH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 48% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 58% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 49% | 2 days ago 72% |
| MACD ODDS (%) | 2 days ago 38% | 2 days ago 66% |
| TrendWeek ODDS (%) | 2 days ago 55% | 2 days ago 67% |
| TrendMonth ODDS (%) | 2 days ago 42% | 2 days ago 68% |
| Advances ODDS (%) | 2 days ago 53% | 2 days ago 64% |
| Declines ODDS (%) | N/A | 6 days ago 68% |
| BollingerBands ODDS (%) | 2 days ago 53% | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 38% | 2 days ago 63% |
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | +0.12% | ||
| FMCQF - AMED | 24% Poorly correlated | N/A | ||
| OPCH - AMED | 23% Poorly correlated | +0.06% | ||
| EHAB - AMED | 21% Poorly correlated | +1.75% | ||
| USPH - AMED | 21% Poorly correlated | +4.43% | ||
| CYH - AMED | 20% Poorly correlated | +10.29% | ||
More | ||||
USPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, USPH has been loosely correlated with NHC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if USPH jumps, then NHC could also see price increases.
| Ticker / NAME | Correlation To USPH | 1D Price Change % | ||
|---|---|---|---|---|
| USPH | 100% | +4.43% | ||
| NHC - USPH | 53% Loosely correlated | +1.59% | ||
| ENSG - USPH | 43% Loosely correlated | +3.58% | ||
| SEM - USPH | 42% Loosely correlated | +2.14% | ||
| EHC - USPH | 39% Loosely correlated | +0.45% | ||
| BKD - USPH | 37% Loosely correlated | N/A | ||
More | ||||